Meta Looks for Exclusive Hollywood Content for its New Headset, WSJ
Meta Platforms, Inc. (NASDAQ:META) is negotiating exclusive immersive content for its future premium virtual reality headgear, internally named "Loma," with Disney, A24, and other companies.
The device, which is set to be released next year, will cost less than $1,000 and look like giant eyeglasses attached to a pocket-sized puck. To compete with Apple's $3,500 Vision Pro, Meta Platforms, Inc. (NASDAQ:META) is paying millions for VR-only versions of popular IPs.
Loma intends to combine immersive video with portability and will have higher-fidelity images than current Meta Quest devices. Disney and James Cameron's Lightstorm Entertainment have previously teamed up with Meta Platforms, Inc. (NASDAQ:META) to create a Star Wars virtual reality experience.
While allowing content to be monetized later on other platforms, the business is giving priority to time-limited VR exclusivity. In 2024, Meta Platforms, Inc. (NASDAQ:META)'s VR/AR business, Reality Labs, reported a $17.7 billion loss on $2.1 billion in revenue. Despite becoming a market leader, its Quest line is still specialized; since 2021, its AI-powered Ray-Ban spectacles have sold two million pairs.
While we acknowledge the potential of META as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock.
READ NEXT: 10 High-Growth EV Stocks to Invest In and 13 Best Car Stocks to Buy in 2025.
Disclosure. None.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
8 minutes ago
- Business Upturn
Bitcoin rebounds above $104,700 after initial dip on Trump-Musk fallout
Bitcoin (BTC) staged a smart recovery on Friday, climbing back above the $104,700 mark after an early dip sparked by jitters in the market following the reported fallout between former US President Donald Trump and tech billionaire Elon Musk. As per latest data, Bitcoin was trading at $104,731.41, up 2.18% over the past 24 hours. The cryptocurrency saw a volatile session, hitting an intraday low of $102,405.29 before bouncing back sharply to test a high of $105,333.00. The market had initially reacted negatively to reports of strained relations between Trump and Musk, which had raised concerns about potential policy shifts or regulatory overhang on digital assets in the US. The development triggered a broad risk-off sentiment across major cryptocurrencies during early trade. However, BTC's resilience was on display as buyers stepped in at lower levels, fueling a strong rebound. The 24-hour trading volume stood robust at 14,435.76 BTC, with $1.5 billion USDT turnover, indicating healthy participation on the bounce. Crypto market analysts noted that despite short-term headlines, underlying bullish momentum in BTC remains intact amid improving institutional interest and optimism around the next leg of mainstream adoption. Traders will be watching closely for further developments on the Trump-Musk front, along with upcoming macroeconomic cues, which could influence BTC's near-term trajectory. Note: $BTC price at the time of writing this article. News desk at
Yahoo
19 minutes ago
- Yahoo
Miley Cyrus Explains How She Used to Hide All of the Money She Spent on Drugs from Her Accountant
Miley Cyrus recalls the days of hiding her drug purchases from those around her The former Disney star visited The Ringer's Every Single Album podcast where she discussed her drug use during Miley Cyrus & Her Dead Petz era She has also openly discussed her sobriety journeyMiley Cyrus is opening up about her past drug use — and how she used to keep it a secret from those around her, specifically her accountant. The music artist, 32, got candid while taking a deep dive into where she was mentally for each of her albums like Bangerz and Endless Summer Vacation, for the Friday, June 6 episode of The Ringer's Every Single Album podcast. During their discussion of her 2015 album, Miley Cyrus & Her Dead Petz, the former Disney star revealed where some of her money went without her accountant's knowledge. 'The drugs were the biggest cost, which to hide those from my accountant, we called them vintage clothes,' Cyrus said. The 'Flowers' singer continued, 'And so she would get these checks. That happens on touring all the time.' Cyrus said over time her accountant would wonder about the "vintage clothes" costs but she always made sure to keep her purchases discreet. 'And every time she saw me, she'd be like, 'Where's that, like, $15,000 original John Lennon T-shirt that you bought?' It's like, 'Oh, it's upstairs,' ' she said. 'We just really want to protect it. It's really delicate. The fabric got to take care of it. So I bought a lot of vintage clothes that year,' Cyrus added. Continuing to reflect on Miley Cyrus & Her Dead Petz, the 'We Can't Stop' singer admitted she's grateful for how far she's come since that period in her life. 'I'm so glad I survived that time in my life," Cyrus said. "I would definitely not encourage anyone else to go this hard, but the fact that I got through it, I'm very glad I got to do it.' Cyrus has been open about her sobriety throughout the passing years. In a 2017 interview with Billboard, she said she was 'evolving' after giving up marijuana. 'I haven't smoked weed in three weeks, which is the longest I've ever [gone without it],' she said at the time. 'I'm not doing drugs, I'm not drinking, I'm completely clean right now! That was just something that I wanted to do.' She later spoke to Rolling Stone for the magazine's January 2021 cover story after she "fell off" and started drinking during the pandemic. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "[I] haven't done drugs in years. Honestly, I never try to, again, be a fortune-teller. I try to not be naive," Cyrus said at the time. "Things f—--- happen. But from sitting here with you right now, I would say it would have to be a cold day in hell for me to relapse on drugs." If you or someone you know is struggling with substance abuse, please contact the SAMHSA helpline at 1-800-662-HELP. Read the original article on People
Yahoo
26 minutes ago
- Yahoo
Palantir and TeleTracking Team Up to Enhance Healthcare Operations Using AI-Driven Insights
TeleTracking Technologies, a leading provider of healthcare operations platforms, has teamed up with Palantir Technologies Inc. (NASDAQ:PLTR), known for its expertise in artificial intelligence systems. The two companies have formed a strategic partnership with the goal of transforming how hospitals and health systems make operational decisions, ultimately creating long-term value for healthcare providers around the world. The collaboration will integrate TeleTracking's Operations IQ platform with Palantir Technologies Inc. (NASDAQ:PLTR)'s AI-driven tools, including Foundry and AIP. This combined solution is expected to equip hospitals with near real-time, actionable insights to improve staffing efficiency, speed up decision-making, and ensure that patient needs remain the top priority. As healthcare systems continue to face increasing demands to enhance capacity and coordination without expanding their physical footprint, this partnership represents a significant step forward. By bringing together TeleTracking's operational strengths and Palantir Technologies Inc. (NASDAQ:PLTR)'s cutting-edge technology, the two aim to usher in a new era of intelligent, scalable, and efficient healthcare delivery. Alex Karp, CEO at Palantir Technologies Inc. (NASDAQ:PLTR) made the following comment: 'This partnership with TeleTracking represents the AI revolution in healthcare we are in the midst of—where we continue to move closer to a world where all hospitals and health systems are embracing, implementing and operating with an AI-powered approach, helping to streamline operations allowing for increased focus on providing the best level of care.' Palantir Technologies Inc. (NASDAQ:PLTR) is an American publicly traded company that focuses on developing software platforms designed for analyzing large volumes of data. While we acknowledge the potential of PLTR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
